Skip to content

A71200 Vanta" Clinician Programmer Application (CP App)… recallZ-1043-2026 · Medtronic Neuromodulation · initiated Dec 3, 2025

Open, Classified

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Medtronic Neuromodulation or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

FDA root cause category: Software design

What the company is doing

On December 3, 2025 the firm distributed Urgent Medical Device Safety Notification letters to affected consignees. Customers were instructed to download and install A81200 CP App v2.0.2684 or any later version.

Recall details

Recall number
Z-1043-2026
Status
Open, Classified
Initiated by the company
Dec 3, 2025
Posted by the FDA
Jan 9, 2026
Recalling firm
Medtronic Neuromodulation
Quantity
7123
Product code
LGW
FDA submissions
P840001S594
Distribution
Worldwide - US Nationwide distribution.

Product description

A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).

Code information (models, lots, serial numbers)

version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.

Devices named in this recall

1 device in the FDA device registry whose identifier appears in the recall's code information.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page